Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
316 participants
OBSERVATIONAL
2018-07-18
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visor System
Subjects are monitored one time with the Visor System.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cerebrotech Medical Systems, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher P Kellner, MD
Role: PRINCIPAL_INVESTIGATOR
Sinai Health System
Andrei V Alexandrov, MD
Role: PRINCIPAL_INVESTIGATOR
University of Tennessee
Raul G Nogueira, MD
Role: PRINCIPAL_INVESTIGATOR
Emory University School of Medicine, Grady Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Buffalo Neurosurgery
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Adrian Parker
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Kellner CP, Sauvageau E, Snyder KV, Fargen KM, Arthur AS, Turner RD, Alexandrov AV. The VITAL study and overall pooled analysis with the VIPS non-invasive stroke detection device. J Neurointerv Surg. 2018 Nov;10(11):1079-1084. doi: 10.1136/neurintsurg-2017-013690. Epub 2018 Mar 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CH007
Identifier Type: -
Identifier Source: org_study_id